220 related articles for article (PubMed ID: 7590696)
1. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
[TBL] [Abstract][Full Text] [Related]
2. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
[TBL] [Abstract][Full Text] [Related]
4. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of cyclin D1 in human breast cancer.
Zhang SY; Caamano J; Cooper F; Guo X; Klein-Szanto AJ
Am J Clin Pathol; 1994 Nov; 102(5):695-8. PubMed ID: 7942638
[TBL] [Abstract][Full Text] [Related]
6. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.
Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS
Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas.
Wang X; Pavelic ZP; Li Y; Gleich L; Gartside PS; Pavelic L; Gluckman JL; Stambrook PJ
Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
[TBL] [Abstract][Full Text] [Related]
11. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of glutathione S-transferase pi messenger RNA and its relationship to gene amplification in head and neck squamous cell carcinoma.
Pavelic ZP; Wang X; Li Y; Gleich L; Gluckman JL; Stambrook PJ
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S144-6. PubMed ID: 9065650
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma.
el-Naggar AK; Steck K; Batsakis JG
Cytometry; 1995 Sep; 21(1):47-51. PubMed ID: 8529470
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma.
Frierson HF; Gaffey MJ; Zukerberg LR; Arnold A; Williams ME
Mod Pathol; 1996 Jul; 9(7):725-30. PubMed ID: 8832554
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
Kurzrock R; Ku S; Talpaz M
Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927
[TBL] [Abstract][Full Text] [Related]
18. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
[TBL] [Abstract][Full Text] [Related]
19. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
